CorVel Corp. 10-Q Summary: Quarter Ended December 31, 2007
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended December 31, 2007, and the nine-month period ended on the same date. CorVel Corporation is an independent nationwide provider of medical cost containment and managed care services, primarily serving the workers' compensation and auto insurance industries. The company operates in a single reportable segment: managed care.
Key Financial Metrics
| Metric | Three Months Ended Dec 31, 2007 | Nine Months Ended Dec 31, 2007 |
|---|---|---|
| Revenues | $76.7 million | $224.5 million |
| Net Income | $6.0 million | $17.2 million |
| Diluted EPS | $0.43 | $1.22 |
| Gross Margin | 26.6% | 25.5% |
| Cash and Equivalents | $15.0 million (Balance Sheet) | $11.3 million (Cash Flow End) |
| Operating Cash Flow (9mo) | $27.7 million | |
| Debt | No outstanding revolving loans; $5.8 million in letters of credit issued. |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 15.2% ($10.1 million) for the quarter and 10.2% ($20.9 million) for the nine months compared to the prior year periods. This growth was primarily driven by the acquisitions of Hazelrigg Risk Management Services (Jan 2007) and The Schaffer Companies (June 2007). Excluding acquisitions, organic revenue growth was approximately 4% for the quarter.
- Profitability: Net income increased 56.5% for the quarter and 29.3% for the nine months. Diluted EPS rose 59.3% to $0.43 for the quarter, aided by both higher pre-tax income and a reduction in weighted average shares due to stock repurchases.
- Cost Structure: Cost of revenues increased 10.2% for the quarter, largely due to the new acquisitions. However, the gross profit margin improved from 23.3% to 26.6% due to reduced operating costs in patient management and IT efficiencies.
- Share Count: Weighted average diluted shares decreased by 2.8% (404,000 shares) due to the company's active share repurchase program.
Guidance, Outlook, and Risks
Management Commentary: Management attributes revenue growth to acquisitions and improved pricing in network solutions. However, they note challenging market conditions, including a decline in manufacturing employment and workers' compensation claims, which creates a flat-to-declining market environment. The company expects nominal growth in referral volumes until work-related injuries increase.
Liquidity and Capital: The company maintains a $10 million revolving credit facility (expires Sept 2008) with no outstanding borrowings. Cash on hand is $11.3 million. Management believes current cash, operating cash flow, and the credit facility are sufficient for operations and acquisitions for the next 12 months.
Internal Controls: The company disclosed that its disclosure controls and procedures were not effective as of December 31, 2007, due to material weaknesses identified in the prior fiscal year. These weaknesses relate to the control environment, segregation of duties, income tax accounting, and financial close processes. Remediation efforts, including software upgrades and hiring external experts, are ongoing.
Risks: Key risks include changes in government regulations, litigation exposure regarding medical treatment recommendations, competition from larger insurers performing services in-house, and the potential for goodwill impairment.
Investor Verification Checklist
- Verify the status of remediation for the material weaknesses in internal controls over financial reporting.
- Monitor the integration and performance of the Hazelrigg and Schaffer acquisitions, including the achievement of earnout targets ($2.5M and $3.0M respectively).
- Assess the impact of declining workers' compensation claims and manufacturing employment on organic revenue growth.
- Review the company's ability to maintain gross margins amidst competitive pricing pressures and rising labor costs.
- Confirm the company's adherence to loan covenants (current ratio > 1.25:1, debt-to-tangible net worth < 1:1) under the new credit facility.